原生干细胞转录回路定义了高风险白血病的核心特征
Qing Wang1, Francesco Boccalatte2,3, Jason Xu4
1Division of Hematology-Oncology, Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA.
The Journal of experimental medicine
|February 19, 2025
概括
研究人员确定了一个ZMIZ1-MYB信号网络,该网络驱动早期T细胞前体急性淋巴细胞白血病 (ETP-ALL) 干. 针对这个网络可能为高风险ETP-ALL提供一个安全的治疗策略.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 早期T细胞前体急性淋巴细胞白血病 (ETP-ALL) 的突变格局已知,但缺乏其干细胞基因激活的统一框架.
- ETP-ALL是一种异质性疾病,具有明显的分子特征和积极的临床行为.
研究的目的:
- 在ETP-ALL中建立干细胞基因激活的统一框架.
- 确定高风险ETP-ALL中关键的分子驱动因素和治疗点.
主要方法:
- 利用互补的老鼠和人类模型.
- 进行了染色体映射和增强剂概况.
- 研究了ZMIZ1和MYB在ETP-ALL病变发生中的作用.
主要成果:
- 联合激活剂ZMIZ1诱导MYB,通过输送电路和基本增强剂激活瘤基因 (MEF2C,MYCN,BCL2).
- 一个关键的超级增强剂NMRE驱动恶性ETP生长,但对于正常的淋巴发育是不可或缺的.
- 这种超级增强器网络识别了耐治疗的ETP-ALL,并且与生存率差相关.
结论:
- ZMIZ1-MYB网络统一了各种ETP-ALL,并解释了高风险BMP类ETP-ALL的关键特征.
- 针对ZMIZ1,这是不可或缺的平衡,为高风险ETP-ALL提供了潜在的治疗策略.
- 这项研究为了解ETP-ALL干性提供了一个统一的框架,并确定了一个有前途的治疗漏洞.
相关概念视频
01:21Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
01:21Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
01:01Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
02:40Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K
01:06Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
01:19Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K